You haven't justified your claim that Investors could lose the LOT.
How is this likely?
Also thanks for misrepresenting my statements:
I didn't say Sirtex was exactly comparable, I used it as an example of how disappointing clinical trials will not necessarily result in delisting of the stock and shareholders losing everything.
Also Sirtex doesn't have a wide portfolio of patents, and a platform of multiple applications like MSB does.
BUT it is your claim that investors could lose the lot, and it's a timely exaggeration.
What is the likelihood of it happening? It's your claim not mine!
Justify it.
You haven't justified your claim that Investors could lose the...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |